FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for improving uterine cicatrix. That is ensured by administering mesenchymal stem cells derived from perivascular space of umbilical cord. Said cells are applied on gel-based matrix of sodium carboxymethyl cellulose and hyaluronic acid in final concentration of 1.5*106/ml. Matrix is placed in the area of the cicatrix in dose of 300 thousand cells in 250 mcl of the carrier solution.
EFFECT: invention provides stimulating uterine cicatrisation.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING THE CULTURE OF MESENCHYMAL HUMAN STEM CELLS FROM THE PERIVASCULAR SPACE OF THE VEIN OF UMBILICAL CORD | 2015 |
|
RU2620981C2 |
| METHOD FOR OBTAINING AN INJECTABLE RESORBABLE IMPLANT BASED ON POLYCAPROLACTONE AND MULTIPOTENT STORMAL CELLS FROM UMBILICAL CORD | 2017 |
|
RU2660550C1 |
| METHOD FOR TREATING THE DISEASES OF DIFFERENT ETIOLOGY AND TRAUMAS OF DIFFERENT ORGANS | 2005 |
|
RU2301667C1 |
| METHOD OF PRODUCING TISSUE-ENGINEERED PERIOSTEUM FROM CELL SPHEROIDS FOR REPAIRING BONE DEFECTS OF SUBJECT | 2022 |
|
RU2819284C2 |
| METHOD FOR STIMULATING REGENERATION OF MUSCULAR BRANCHES OF FACIAL NERVE IN EXPERIMENT | 2018 |
|
RU2700258C1 |
| TREATMENT METHOD OF LIVE FAILURE | 2016 |
|
RU2618989C1 |
| METHOD OF POSTINFARCTION REMODELLED CARDIAC MUSCLE PREPARATION FOR INTRAMYOCARDIAL CELL TRANSPLANTATION IN EXPERIMENT | 2009 |
|
RU2412658C2 |
| METHOD FOR CREATING A TISSUE-ENGINEERED VASCULAR IMPLANT BASED ON A TUBULAR BIODEGRADABLE POLYMER MATRIX OF POLY(L-LACTIDE) MICROFIBERS | 2018 |
|
RU2698133C1 |
| METHOD FOR A BIORESORABLE MESH IMPLANT OBTAINING FOR THE PELVIC WALLS AND ABDOMINAL CAVITY PLASTIC RECONSTRUCTION | 2016 |
|
RU2648355C1 |
| METHOD OF TREATING HEPATIC FAILURE | 2015 |
|
RU2586952C1 |
